IRIS
metadata only
What is new on the horizon for the biologics world: New kids of the block – WAO state of art
Background: Advances in the understanding of type 2 inflammation have driven the development of novel biologics and small molecules for allergic diseases. New therapies targeting cytokines, receptors, and intracellular pathways offer opportunities to refine disease management and modify long-term ou
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Targeting type 2 inflammation in dermatology: mechanisms and clinical implications.#630958
- Role of extracellular vesicles in allergic sensitization#466528
- Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.#893701
- Tissue factor and regenerative medicine: shaping cell and extracellular vesicle-based therapeutic approaches.#465206
- Extracellular Vesicles in Allergy: From Cellular Communication to Clinical Implications.#148225
Record · ID 971325
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive